{"id":"https://openalex.org/W2149933426","doi":"https://doi.org/10.1096/fj.02-0204fje","title":"Prostacyclin derivatives prevent the fibrotic response to TGF\u03b22 by inhibiting the Ras/MEK/ERK pathway","display_name":"Prostacyclin derivatives prevent the fibrotic response to TGF\u03b22 by inhibiting the Ras/MEK/ERK pathway","alternate_titles":[],"publication_year":2002,"publication_date":"2002-10-04","ids":{"openalex":"https://openalex.org/W2149933426","doi":"https://doi.org/10.1096/fj.02-0204fje","mag":"2149933426","pmid":"https://pubmed.ncbi.nlm.nih.gov/12368229"},"language":"en","primary_location":{"id":"doi:10.1096/fj.02-0204fje","doi":"https://doi.org/10.1096/fj.02-0204fje","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fj.02-0204fje","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2149933426"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088985859","display_name":"Richard J. Stratton","orcid":"https://orcid.org/0000-0002-2948-6919","observed_orcids":["https://orcid.org/0000-0002-2948-6919"]},"institutions":[{"id":"https://openalex.org/I2801138448","display_name":"The Royal Free Hospital","ror":"https://ror.org/01ge67z96","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I169248724","https://openalex.org/I2801138448"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Richard Stratton","raw_affiliation_strings":["Centre for RheumatologyRoyal Free Hospital and University College School of Medicine Rowland Hill Street London NW3 2PF UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for RheumatologyRoyal Free Hospital and University College School of Medicine Rowland Hill Street London NW3 2PF UK","institution_ids":["https://openalex.org/I2801138448","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041223461","display_name":"Vineeth S. Rajkumar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801138448","display_name":"The Royal Free Hospital","ror":"https://ror.org/01ge67z96","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I169248724","https://openalex.org/I2801138448"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Vineeth Rajkumar","raw_affiliation_strings":["Centre for RheumatologyRoyal Free Hospital and University College School of Medicine Rowland Hill Street London NW3 2PF UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for RheumatologyRoyal Free Hospital and University College School of Medicine Rowland Hill Street London NW3 2PF UK","institution_ids":["https://openalex.org/I2801138448","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102804281","display_name":"Markella Ponticos","orcid":"https://orcid.org/0000-0001-5957-5851","observed_orcids":["https://orcid.org/0000-0001-5957-5851"]},"institutions":[{"id":"https://openalex.org/I2801138448","display_name":"The Royal Free Hospital","ror":"https://ror.org/01ge67z96","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I169248724","https://openalex.org/I2801138448"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Markella Ponticos","raw_affiliation_strings":["Centre for RheumatologyRoyal Free Hospital and University College School of Medicine Rowland Hill Street London NW3 2PF UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for RheumatologyRoyal Free Hospital and University College School of Medicine Rowland Hill Street London NW3 2PF UK","institution_ids":["https://openalex.org/I2801138448","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079729963","display_name":"Blake Nichols","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210136455","display_name":"FibroGen (United States)","ror":"https://ror.org/03sxe1905","country_code":"US","type":"company","lineage":["https://openalex.org/I4210136455"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Blake Nichols","raw_affiliation_strings":["FibroGen, Inc. 225 Gateway Blvd. South San Francisco CA 94080"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FibroGen, Inc. 225 Gateway Blvd. South San Francisco CA 94080","institution_ids":["https://openalex.org/I4210136455"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Xu Shiwen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801138448","display_name":"The Royal Free Hospital","ror":"https://ror.org/01ge67z96","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I169248724","https://openalex.org/I2801138448"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Xu Shiwen","raw_affiliation_strings":["Centre for RheumatologyRoyal Free Hospital and University College School of Medicine Rowland Hill Street London NW3 2PF UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for RheumatologyRoyal Free Hospital and University College School of Medicine Rowland Hill Street London NW3 2PF UK","institution_ids":["https://openalex.org/I2801138448","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113513578","display_name":"Carol M. Black","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801138448","display_name":"The Royal Free Hospital","ror":"https://ror.org/01ge67z96","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I169248724","https://openalex.org/I2801138448"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Carol M. Black","raw_affiliation_strings":["Centre for RheumatologyRoyal Free Hospital and University College School of Medicine Rowland Hill Street London NW3 2PF UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for RheumatologyRoyal Free Hospital and University College School of Medicine Rowland Hill Street London NW3 2PF UK","institution_ids":["https://openalex.org/I2801138448","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015770154","display_name":"David Abraham","orcid":"https://orcid.org/0000-0001-8952-6057","observed_orcids":["https://orcid.org/0000-0001-8952-6057"]},"institutions":[{"id":"https://openalex.org/I2801138448","display_name":"The Royal Free Hospital","ror":"https://ror.org/01ge67z96","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I169248724","https://openalex.org/I2801138448"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David J. Abraham","raw_affiliation_strings":["Centre for RheumatologyRoyal Free Hospital and University College School of Medicine Rowland Hill Street London NW3 2PF UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for RheumatologyRoyal Free Hospital and University College School of Medicine Rowland Hill Street London NW3 2PF UK","institution_ids":["https://openalex.org/I2801138448","https://openalex.org/I45129253"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085867011","display_name":"Andrew Leask","orcid":"https://orcid.org/0000-0003-2832-283X","observed_orcids":["https://orcid.org/0000-0003-2832-283X"]},"institutions":[{"id":"https://openalex.org/I4210136455","display_name":"FibroGen (United States)","ror":"https://ror.org/03sxe1905","country_code":"US","type":"company","lineage":["https://openalex.org/I4210136455"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Andrew Leask","raw_affiliation_strings":["FibroGen, Inc. 225 Gateway Blvd. South San Francisco CA 94080"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FibroGen, Inc. 225 Gateway Blvd. South San Francisco CA 94080","institution_ids":["https://openalex.org/I4210136455"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3740,"currency":"USD","value_usd":3740},"apc_paid":null,"fwci":2.3566,"has_fulltext":false,"cited_by_count":159,"citation_normalized_percentile":{"value":0.88752278,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"16","issue":"14","first_page":"1949","last_page":"1951"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11501","display_name":"TGF-\u03b2 signaling in diseases","score":0.8574000000953674,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11501","display_name":"TGF-\u03b2 signaling in diseases","score":0.8574000000953674,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11330","display_name":"Systemic Sclerosis and Related Diseases","score":0.06989999860525131,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13223","display_name":"Connective Tissue Growth Factor Research","score":0.050700001418590546,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/connective-tissue-growth-factor","display_name":"connective tissue growth factor","score":0.8389999866485596},{"id":"https://openalex.org/keywords/tgf-beta2","display_name":"TGF-beta2","score":0.9300000071525574},{"id":"https://openalex.org/keywords/fibrosis","display_name":"fibrosis","score":0.765999972820282},{"id":"https://openalex.org/keywords/ras-mek-erk-pathway","display_name":"Ras/MEK/ERK pathway","score":0.9340000152587891},{"id":"https://openalex.org/keywords/protein-kinase-a","display_name":"protein kinase A","score":0.8799999952316284},{"id":"https://openalex.org/keywords/smad-signaling","display_name":"Smad signaling","score":0.996999979019165},{"id":"https://openalex.org/keywords/fibroblasts","display_name":"fibroblasts","score":0.921999990940094},{"id":"https://openalex.org/keywords/systemic-sclerosis","display_name":"systemic sclerosis","score":0.9850000143051147},{"id":"https://openalex.org/keywords/antifibrotic-therapy","display_name":"antifibrotic therapy","score":0.8709999918937683},{"id":"https://openalex.org/keywords/signaling-crosstalk","display_name":"signaling crosstalk","score":0.7480000257492065}],"concepts":[{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.7936313152313232},{"id":"https://openalex.org/C2781080636","wikidata":"https://www.wikidata.org/wiki/Q700000","display_name":"SMAD","level":3,"score":0.7130383849143982},{"id":"https://openalex.org/C2780631158","wikidata":"https://www.wikidata.org/wiki/Q14907752","display_name":"CTGF","level":4,"score":0.7047667503356934},{"id":"https://openalex.org/C2775960820","wikidata":"https://www.wikidata.org/wiki/Q408378","display_name":"Growth factor","level":3,"score":0.574661910533905},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5578728318214417},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.5246363282203674},{"id":"https://openalex.org/C118131993","wikidata":"https://www.wikidata.org/wiki/Q423671","display_name":"Transforming growth factor","level":2,"score":0.48800864815711975},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.44877350330352783},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.44370752573013306},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.4373219609260559},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36602258682250977},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3611301779747009},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.30358582735061646},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.25089073181152344},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.13771376013755798}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004268","descriptor_name":"DNA-Binding Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005347","descriptor_name":"Fibroblasts","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005355","descriptor_name":"Fibrosis","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D015534","descriptor_name":"Trans-Activators","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016212","descriptor_name":"Transforming Growth Factor beta","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D016283","descriptor_name":"Proto-Oncogene Proteins p21(ras)","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D016285","descriptor_name":"Iloprost","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017868","descriptor_name":"Cyclic AMP-Dependent Protein Kinases","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D017874","descriptor_name":"Immediate-Early Proteins","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D017874","descriptor_name":"Immediate-Early Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D020928","descriptor_name":"Mitogen-Activated Protein Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D020929","descriptor_name":"Mitogen-Activated Protein Kinase Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D020935","descriptor_name":"MAP Kinase Signaling System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D036341","descriptor_name":"Intercellular Signaling Peptides and Proteins","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D036341","descriptor_name":"Intercellular Signaling Peptides and Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051785","descriptor_name":"Smad Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055513","descriptor_name":"Connective Tissue Growth Factor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1096/fj.02-0204fje","doi":"https://doi.org/10.1096/fj.02-0204fje","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fj.02-0204fje","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"},{"id":"pmid:12368229","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12368229","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","raw_type":"Journal Article"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:1306013","doi":null,"is_oa":false,"landing_page_url":"http://discovery.ucl.ac.uk/1306013/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"The FASEB journal : official publication of the Federation of American Societies for Experimental Biology , 16 (14) pp. 1949-1951. (2002)","raw_type":"Article"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:190909","doi":null,"is_oa":false,"landing_page_url":"http://discovery.ucl.ac.uk/190909/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"FASEB J , 16 (12) 1949 - +. (2002)","raw_type":"Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G779467174","display_name":"RECOMBINANT HUMAN COLLAGEN &CTGF FOR TISSUE ENGINEERING","funder_award_id":"R01AR045879","funder_id":"https://openalex.org/F4320337362","funder_display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337362","display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","ror":"https://ror.org/006zn3t30"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":47,"referenced_works":["https://openalex.org/W263572369","https://openalex.org/W1494055834","https://openalex.org/W1560334098","https://openalex.org/W1590606509","https://openalex.org/W1663371441","https://openalex.org/W1816605246","https://openalex.org/W1942474822","https://openalex.org/W1952271883","https://openalex.org/W1965344790","https://openalex.org/W1978991205","https://openalex.org/W1993876642","https://openalex.org/W2001093897","https://openalex.org/W2005566723","https://openalex.org/W2009893232","https://openalex.org/W2028934257","https://openalex.org/W2029144169","https://openalex.org/W2029427032","https://openalex.org/W2043324719","https://openalex.org/W2045141910","https://openalex.org/W2050022621","https://openalex.org/W2055384530","https://openalex.org/W2061449760","https://openalex.org/W2068419762","https://openalex.org/W2069911905","https://openalex.org/W2080794445","https://openalex.org/W2086262311","https://openalex.org/W2087027548","https://openalex.org/W2087307986","https://openalex.org/W2088675636","https://openalex.org/W2089455607","https://openalex.org/W2098118477","https://openalex.org/W2098468369","https://openalex.org/W2109538717","https://openalex.org/W2115471698","https://openalex.org/W2119727612","https://openalex.org/W2134736486","https://openalex.org/W2135664105","https://openalex.org/W2144533837","https://openalex.org/W2152155828","https://openalex.org/W2161431449","https://openalex.org/W2162291763","https://openalex.org/W2163598311","https://openalex.org/W2165037989","https://openalex.org/W2316067769","https://openalex.org/W2441700042","https://openalex.org/W3134071211","https://openalex.org/W6809235560"],"related_works":["https://openalex.org/W2092260863","https://openalex.org/W2006973776","https://openalex.org/W2093733315","https://openalex.org/W2062801814","https://openalex.org/W2740836574","https://openalex.org/W2896824926","https://openalex.org/W2064331937","https://openalex.org/W1995721099","https://openalex.org/W2163785679"],"abstract_inverted_index":{"The":[0,130],"SMAD-mediated":[1,42],"induction":[2,43,82],"of":[3,22,34,44,53,83,106,119,145,153,165],"connective":[4],"tissue":[5],"growth":[6,14],"factor":[7,15],"(CTGF),":[8],"a":[9],"fibroproliferative":[10],"cytokine,":[11],"by":[12,46],"transforming":[13],"(TGF)beta":[16],"is":[17,38,60],"required":[18,39],"for":[19,40],"the":[20,35,41,68,81,91,98,120,143],"development":[21],"sustained":[23],"fibrosis":[24,159],"in":[25,31,58,85,88,99,102,139],"humans.":[26],"Here,":[27,95],"we":[28,72,96],"show":[29,50,110],"that":[30,51,74,111],"fibroblasts,":[32,86],"activation":[33,52],"Ras/MEK/ERK":[36,64,121,123,155],"pathway":[37],"CTGF":[45,84],"TGFbeta2.":[47],"We":[48],"then":[49],"protein":[54],"kinase":[55],"A":[56],"(PKA)":[57],"fibroblasts":[59],"able":[61,78],"to":[62,79,116,136,142],"block":[63],"signaling":[65,146,156],"and":[66,87,101,109,132],"abolish":[67],"fibrotic":[69,92],"response.":[70],"Previously,":[71],"found":[73],"prostacyclin":[75,107],"agonists":[76],"were":[77],"prevent":[80,158],"patients":[89],"with":[90],"disease":[93],"scleroderma.":[94],"confirm":[97],"vitro":[100],"vivo":[103],"antifibrotic":[104],"effects":[105,113,164],"derivatives":[108],"these":[112],"are":[114,138],"due":[115,141],"PKA-dependent":[117],"inhibition":[118,152],"pathway.":[122],"does":[124],"not":[125],"directly":[126],"affect":[127],"SMAD":[128],"signaling.":[129],"coordinate":[131],"varied":[133],"biological":[134],"responses":[135],"TGFbeta":[137,166],"part":[140],"interactions":[144],"pathways":[147],"within":[148],"target":[149],"cells.":[150],"Specific":[151],"fibroblast":[154],"might":[157],"while":[160],"leaving":[161],"other":[162],"physiological":[163],"unaltered.":[167]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2149933426","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
